Background:Globicatella Sanguinis is a germ that is rarely isolated in practice however, in view of identification errors due to its resemblance to viridans streptococci and the difficulties presented by many commercial systems of phenotypic identification, this pathogen remains underappreciated. Several works have highlighted the isolation of this bacteria, but the clinical characteristics and modes of infestation are still unknown. Case presentation:A 82-year-old Moroccan woman with high blood pressure and type 2 diabetes was discovered unconscious and transferred to our unit for medical care. He was immunocompetent with no history of malignancies, recurrent infections or immunosuppression medications. The investigation of the febrile consciousness disorder presented by the patient reveled Globicatella sanguinis in blood cultures. All other septic simples were negative. The evolution was marked by apyrexia, and an improvement in her state of awareness after rehydration, antimicrobial medication, glycemic and blood pressure rebalancing. Conclusions:This is the first case of Globicatella sanguinis isolation in our department. Literature review shows a high MIC level against third generation cephalosporins. In light of the increasing emergence of drug-resistant bacteria, the establishment of appropriate antibiotics has become an imperative necessity. However, more researches are required to look into the pathophysiology and risk factors of G. sanguinis infections among humans. Its low occurrence may be attributable in part to difficulties in laboratory identification, and it is probable that recognition of this organism will improve when modern technologies such as MALDI-TOF MS and next-generation sequencing become more widely used.